Company intelligence / Profile preview

HoneyBear Biosciences, Inc

Ownership: Private
Development stage: Preclinical

Overview

HoneyBear Biosciences is a Taiwan-based biotech company founded in 2021. It specializes in next-generation antibody-drug conjugate technologies using its proprietary CoNectar™ platform for precise and dual payload attachment. The company has received industry recognition for innovation in ADCs, including the “Best ADC Developer in Taiwan” award at the 2025 Asia-Pacific Biopharma Excellence Awards. Recent partnerships include licensing deals with Singapore’s A*STAR to accelerate development of Antibody Radionuclide Conjugates for cancer therapy. Clinical results are not yet available; programs are preclinical or entering early clinical stages[3][4][5].

Therapeutic areas: Oncology
Modalities: Antibody-drug conjugates (ADCs)Antibody radionuclide conjugates (ARCs)
Industry: Biotech

Drug pipeline

1 asset

HB001

Unknown

Partnerships

Agency for Science, Technology and Research (A*STAR), Singapore – exclusive antibody license and multi-cistronic expression vector technology for ARC program[5].Multiple co-development/licensing partnerships with global biotech/pharma companies targeted as part of business strategy[1][7].

Beyond the preview

Go deeper on HoneyBear Biosciences, Inc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HoneyBear Biosciences, Inc.

Explore the full profile